首页> 外文期刊>Indian Journal of Microbiology >Antibacterial Efficacy of Dihydroxylated Chalcones in Binary and Ternary Combinations with Nalidixic Acid and Nalidix Acid–Rutin Against Escherichia coli ATCC 25 922
【24h】

Antibacterial Efficacy of Dihydroxylated Chalcones in Binary and Ternary Combinations with Nalidixic Acid and Nalidix Acid–Rutin Against Escherichia coli ATCC 25 922

机译:萘啶酸和萘啶酸-芦丁二元和三元组合中二羟基化查尔酮对大肠杆菌ATCC的抗菌作用25 922

获取原文
获取原文并翻译 | 示例
           

摘要

In order to determine the existence of synergism, the bacteriostatic action of flavonoids against Escherichia coli ATCC 25 922 between dihydroxylated chalcones and a clinically interesting conventional antibiotic, binary combinations of 2′,3-dihydroxychalcone, 2′,4-dihydroxychalcone and 2′,4′-dihydroxychalcone with nalidixic acid and its ternary combinations with rutin (inactive flavonoid) were assayed against this Gram negative bacterium. Using a kinetic-turbidimetric method, growth kinetics were monitored in broths containing variable amounts of dihydroxychalcone alone, combinations of dihydroxychalcone variable concentration–nalidixic acid constant concentration and dihydroxychalcone variable concentration–nalidixic acid constant concentration–rutin constant concentration, respectively. The minimum inhibitory concentrations of dihydroxychalcones alone and its binary and ternary combinations were evaluated. All chalcones, and their binary and ternary combinations showed antibacterial activity, being rutin an excellent synergizing for the dihydroxychalcone–nalidixic acid binary combination against E. coli ATCC 25 922. Thus, this synergistic effect is an important way that could lead to the development of new combination antibiotics against infections caused by E. coli.
机译:为了确定协同作用的存在,类黄酮对二羟基化查耳酮与临床上常用的常规抗生素之间的大肠杆菌ATCC 25 922的抑菌作用,即2',3-二羟基查耳酮,2',4-二羟基查耳酮和2'的二元组合,针对该革兰氏阴性细菌,测定了带有萘啶酸的4'-二羟基查尔酮及其与芦丁的三元组合(非活性类黄酮)。使用动力学比浊法,分别监测含有可变量的二羟基查耳酮,二羟基查尔酮可变浓度–萘啶酸恒定浓度和二羟基查尔酮可变浓度–萘啶酸恒定浓度–芦丁恒定浓度的肉汤的生长动力学。评价了单独的二羟基查耳酮及其二元和三元组合的最小抑制浓度。所有查耳酮及其二元和三元组合均显示出抗菌活性,芦丁是二羟基查耳酮-萘二酸二元组合抗大肠杆菌ATCC 25 922的极佳增效作用。因此,这种增效作用是可能导致甲壳素发展的重要途径。新组合抗生素可抵抗大肠杆菌引起的感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号